Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Sullivan

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Infection|January 19, 2024
Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020Mark McMillan, Hassen Mohammed, Jana Bednarz, et al.
Nutrients|January 21, 2023
Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled TrialKaren P Best, Thomas R Sullivan, Anoja W Gunaratne, et al.
Nutrition Journal|April 16, 2026
Body mass index, prebiotic supplementation during pregnancy and gestational diabetes mellitus risk: an effect modification analysis from a randomised controlled trialRachelle A Pretorius, Thomas R Sullivan, Summer V M Walker, et al.
Nutrients|May 7, 2020
Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect RiskShannon E Hunt, Merryn J Netting, Thomas R Sullivan, et al.
BMJ Open|September 22, 2023
Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trialThomas R Sullivan, Lisa N Yelland, Robert A Gibson, et al.
BMC Pediatrics|June 3, 2016
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestationCarmel T Collins, Robert A Gibson, Maria Makrides, et al.
JAMA Network Open|March 21, 2023
Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysisIsabelle Marc, Amélie Boutin, Etienne Pronovost, et al.
BMJ Open|October 9, 2025
Nuts For Babies Study: protocol for a randomised controlled trial in Australia investigating if the risk of developing peanut and cashew nut allergies during infancy can be reduced by a high peanut and cashew nut maternal diet for the first 6 months of lactationThomas R Sullivan, Vicki McWilliam, Michael O'Sullivan, et al.
Pediatrics|November 4, 2008
Candidate genes and cerebral palsy: a population-based studyCatherine S Gibson, Alastair H Maclennan, Gustaaf A Dekker, et al.
Developmental Medicine and Child Neurology|May 9, 2020
Linking data from a large clinical trial with the Australian Cerebral Palsy RegisterEmily Shepherd, Sarah Mcintyre, Hayley Smithers-Sheedy, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Infection|January 19, 2024
Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020Mark McMillan, Hassen Mohammed, Jana Bednarz, et al.
Nutrients|January 21, 2023
Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled TrialKaren P Best, Thomas R Sullivan, Anoja W Gunaratne, et al.
Nutrition Journal|April 16, 2026
Body mass index, prebiotic supplementation during pregnancy and gestational diabetes mellitus risk: an effect modification analysis from a randomised controlled trialRachelle A Pretorius, Thomas R Sullivan, Summer V M Walker, et al.
Nutrients|May 7, 2020
Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect RiskShannon E Hunt, Merryn J Netting, Thomas R Sullivan, et al.
BMJ Open|September 22, 2023
Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trialThomas R Sullivan, Lisa N Yelland, Robert A Gibson, et al.
BMC Pediatrics|June 3, 2016
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestationCarmel T Collins, Robert A Gibson, Maria Makrides, et al.
JAMA Network Open|March 21, 2023
Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysisIsabelle Marc, Amélie Boutin, Etienne Pronovost, et al.
BMJ Open|October 9, 2025
Nuts For Babies Study: protocol for a randomised controlled trial in Australia investigating if the risk of developing peanut and cashew nut allergies during infancy can be reduced by a high peanut and cashew nut maternal diet for the first 6 months of lactationThomas R Sullivan, Vicki McWilliam, Michael O'Sullivan, et al.
Pediatrics|November 4, 2008
Candidate genes and cerebral palsy: a population-based studyCatherine S Gibson, Alastair H Maclennan, Gustaaf A Dekker, et al.
Developmental Medicine and Child Neurology|May 9, 2020
Linking data from a large clinical trial with the Australian Cerebral Palsy RegisterEmily Shepherd, Sarah Mcintyre, Hayley Smithers-Sheedy, et al.
Pageof 10